RESEARCH SUMMARY Study Title: Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma...
Vous n'êtes pas connecté
A new personalized cancer vaccine has shown encouraging results in preventing the return of kidney cancer after surgery. Researchers at Dana-Farber Cancer Institute tested the vaccine in nine patients with stage III or IV clear cell renal cell carcinoma (a form of kidney cancer). All patients remained cancer-free at a median follow-up of nearly three years. The […] The post New cancer vaccine could prevent kidney cancer recurrence appeared first on Knowridge Science Report.
RESEARCH SUMMARY Study Title: Belzutifan plus cabozantinib as first-line treatment for patients with advanced clear-cell renal cell carcinoma...
Data analysis from a randomised clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham Cancer Center, USA, found...
THURSDAY, Feb. 6, 2025 -- Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell...
THURSDAY, Feb. 6, 2025 -- A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successful,...
A new experimental vaccine could provide fresh hope for women diagnosed with triple-negative breast cancer, a particularly aggressive and...
Before surgery, many patients go through a series of tests, such as blood work and heart rhythm checks. However, not all these tests are necessary. In...
WEDNESDAY, Jan. 29, 2025 -- Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study...
The three OTs in the department of renal transplant surgery were closed since 2022 due to faulty air-conditioning system
The three OTs in the department of renal transplant surgery were closed since 2022 due to faulty air-conditioning system
Researchers from the University of Brasília, Brazil, have investigated how cell-free DNA (cfDNA) levels in the blood change before, during, and after...